Paul Tudor Jones's ORIC Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 42,409 shares of ORIC Pharmaceuticals, Inc. (ORIC) worth $459,289, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in ORIC for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 35,285 shares. Largest reduction occurred in Q3 2025, reducing 33,530 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's ORIC Pharmaceuticals (ORIC) Holding Value Over Time
Track share changes against reported price movement
Quarterly ORIC Pharmaceuticals (ORIC) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +8,721 | Add 25.89% | 42,409 | $10.83 |
| Q1 2026 | +33,688 | New Buy | 33,688 | $12.67 |
| Q3 2025 | -33,530 | Sold Out | 0 | $0.00 |
| Q2 2025 | -1,755 | Reduce 4.97% | 33,530 | $10.15 |
| Q1 2025 | +35,285 | New Buy | 35,285 | $5.58 |
| Q3 2024 | -33,391 | Sold Out | 0 | $0.00 |
| Q2 2024 | +4,186 | Add 14.33% | 33,391 | $7.07 |
| Q1 2024 | +29,205 | New Buy | 29,205 | $13.75 |
Paul Tudor Jones's ORIC Pharmaceuticals Investment FAQs
Paul Tudor Jones first purchased ORIC Pharmaceuticals, Inc. (ORIC) in Q1 2024, acquiring 29,205 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held ORIC Pharmaceuticals, Inc. (ORIC) for 8 quarters since Q1 2024.
Paul Tudor Jones's largest addition to ORIC Pharmaceuticals, Inc. (ORIC) was in Q1 2025, adding 35,285 shares worth $196,890.
According to the latest 13F filing for Q2 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 42,409 shares of ORIC Pharmaceuticals, Inc. (ORIC), valued at approximately $459,289.
As of the Q2 2026 filing, ORIC Pharmaceuticals, Inc. (ORIC) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in ORIC Pharmaceuticals, Inc. (ORIC) was 42,409 shares, as reported at the end of Q2 2026.